The atypical antipsychotic sertindole enhances efflux of dopamine and its metabolites in the rat cortex and striatum

European Journal of Pharmacology

Volumn 367, Issue 1, 1999, Pages 19-23

  Watanabe, Masayuki ^a   Hagino, Yoko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Antipsychotic, atypical; Dopamine; Microdialysis; Sertindole

Indexed keywords

DOPAMINE; NEUROLEPTIC AGENT; SERTINDOLE;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOSE RESPONSE; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIPSYCHOTIC AGENTS; DIALYSIS SOLUTIONS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOVANILLIC ACID; IMIDAZOLES; INDOLES; MALE; MICRODIALYSIS; NEOSTRIATUM; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SEROTONIN;

EID: 0033044548     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00936-4     Document Type: Article

References (23)

1. Domeney A.M., Arnt J., Costall B., Naylor R.J., Sanchéz C., Smith A.G. Effect of sertindole on raised mesolimbic dopaminergic activity in the rat. Drug Dev. Res. 31:1994;175-185.
2. Fink-Jensen A., Kristensen P. Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neurosci. Lett. 182:1994;115-118.
3. Fink-Jensen A., Hansen L., Hansen J.B., Nielsen E.B. Regional differences in the effect of haloperidol and atypical neuroleptics on interstitial levels of DOPAC in the rat forebrain: an in vivo microdialysis study. J. Psychopharmacol. 10:1996;119-125.
4. Hertel P., Nomikos G.G., Iurlo M., Svensson T.H. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology. 124:1996;74-86.
5. 1 receptors (ex vivo radioreceptor binding studies). J. Neural Transm. Gen. Sect. 89:1992;61-69.
6. Ichikawa J., Kuroki T., Dai J., Meltzer H.Y. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens. Eur. J. Pharmacol. 351:1998;163-171.
7. Matthews J.N.S., Altman D.G., Campbell M.J., Royston P. Analysis of serial measurements in medical research. Br. Med. J. 300:1990;230-235.
8. Meltzer H.Y., Nash J.F. VII. Effects of antipsychotic drugs on serotonin receptors. Pharmacol. Rev. 43:1991;587-604.
9. Moghaddam B., Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 54:1990;1755-1760.
10. Nomikos G.G., Iurlo M., Andersson J.L., Kimura K., Svensson T.H. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology. 115:1994;147-156.
11. Pehek E.A. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex. Synapse. 24:1996;12-18.
12. Pehek E.A., Yamamoto B.K. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J. Neurochem. 63:1994;2118-2124.
13. Pehek E.A., Meltzer H.Y., Yamamoto B.K. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. Eur. J. Pharmacol. 240:1993;107-109.
14. Pellegrino, L.J., Cushman, A.J., 1967. A Stereotaxic Atlas of the Rat Brain. Appleton-Century-Crofts, New York, NY.
15. Sanchéz C., Arnt J., Dragsted N., Hyttel J., Lembol H.L., Meier E., Perregaard J., Skarsfeldt T. Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Dev. Res. 22:1991;239-250.
16. 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur. J. Pharmacol. 273:1995;273-279.
17. 2 receptor agonists and antagonists. Neuropharmacology. 30:1991;1269-1274.
18. Skarsfeldt T. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment. Synapse. 10:1992;25-33.
19. Volonté M., Monferini E., Cerutti M., Fodritto F., Borsini F. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J. Neurochem. 69:1997;182-190.
20. Watanabe M., Nonaka R., Hagino Y., Kodama Y. Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain. Neurosci. Res. 30:1998;135-144.
21. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669.
22. Westerink B.H.C., de Vries J.B. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci. Lett. 99:1989;197-202.
23. Sertindole Study Group, Zimbroff D.L., Kane J.M., Tamminga C.A., Daniel D.G., Mack R.J., Wozniak P.J., Sebree T.B., Wallin B.A., Kashkin K.B. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Am. J. Psychiatry. 154:1997;782-791.